Skip to Content

Rezira Approval History

  • FDA approved: Yes (First approved June 8th, 2011)
  • Brand name: Rezira
  • Generic name: hydrocodone and pseudoephedrine
  • Dosage form: Oral Solution
  • Company: Cypress Pharmaceutical, Inc.
  • Treatment for: Cough and Nasal Congestion

Rezira (hydrocodone and pseudoephedrine) Oral Solution is a combination product containing an antitussive and nasal decongestant indicated for the relief of cough and nasal congestion associated with the common cold.

Development History and FDA Approval Process for Rezira

Jun 23, 2011Approval FDA Approves Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.